Evidence map›Paper›PMID 32435228›Full record

ArticleFrontiers in neurology2020

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas.

Maya Hrachova, Emely Nhi T Nguyen, Beverly D Fu, Manisha J Dandekar, Xiao-Tang Kong, Gilbert Cadena, Frank P K Hsu, John Billimek, Thomas H Taylor, Daniela A Bota

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  5. Article
  6. Hormone therapies in meningioma-where are we?Journal of neuro-oncology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maya HrachovaDepartment of Neurology, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
Emely Nhi T NguyenSchool of Medicine, University of California, Irvine, Irvine, CA, United States.
Beverly D FuDepartment of Neurology, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
Manisha J DandekarChao Family Comprehensive Cancer Center, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
Xiao-Tang KongDepartment of Neurology, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
Gilbert CadenaChao Family Comprehensive Cancer Center, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
Frank P K HsuChao Family Comprehensive Cancer Center, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
John BillimekSchool of Medicine, University of California, Irvine, Irvine, CA, United States.
Thomas H TaylorDepartment of Epidemiology, University of California, Irvine, Irvine, CA, United States.
Daniela A BotaDepartment of Neurology, Irvine Medical Center, University of California, Orange, Orange, CA, United States.
University of California, Irvine Medical Center · USUniversity of California, Irvine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

meningioma sizemeningioma surgeryoctreotiderecurrent progressive meningiomaskull based meningiomaSomatostatin LAR

Identifiers

PMID32435228
PMCPMC7218113
OpenAlexW3021661002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.